NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancerRaksha R. Bhat, Meghana V. Trivedi, Suhas Vasaikar et al.|Scientific Reports|2022Cited by 27
Abstract 1926: Npy1r as a prognostic marker and a novel drug target in estrogen receptor-positive breast cancerRaksha R. Bhat, Meghana V. Trivedi, Rachel Schiff et al.|Cancer Research|2018Cited by 1